The roles of neuroticism, genetic susceptibility, and amygdala structure in chronic musculoskeletal pain onset and recovery.
TL;DR
High neuroticism scores, neuroticism PRS, and CMP PRS were significantly associated with increased risk of CMP onset and reduced likelihood of recovery across cohorts, highlighting a potential neurobiological mechanism linking psychological vulnerability to chronic pain.
Abstract
Background
Chronic musculoskeletal pain (CMP) represents a significant global health burden, yet the neurobiological mechanisms underlying its development remain poorly understood. This study investigates the complex interplay between neuroticism, genetic risk, and amygdala morphology in CMP onset, recovery, and pain characteristics using UK Biobank data.
Methods
We conducted longitudinal analyses on (1) 9382 pain-free individuals followed for CMP development and (2) 3460 CMP patients tracked for recovery outcomes. Neuroticism was quantified via a validated 12-item questionnaire assessing psychological distress. To assess chronic pain trajectories, we examined polygenic risk scores (PRS) for CMP and neuroticism, along with amygdala grey matter volumes, as predictors. Multivariate logistic and linear regression models were employed, followed by mediation analyses to elucidate underlying relationships between variables. Analyses were restricted to individuals of European ancestry.
Results
We found that higher neuroticism scores, neuroticism PRS, and CMP PRS were significantly associated with increased risk of CMP onset and reduced likelihood of recovery across cohorts (all Pcorrected < 0.05). Both neuroticism scores and PRS were positively correlated with pain intensity, whereas CMP PRS were not. Additionally, amygdala grey matter volumes were significantly associated with neuroticism in the CMP onset cohort but not in the recovery group. Neuroticism mediated the relationship between CMP PRS and subsequent CMP onset with a small effect size, while no mediation was observed for CMP recovery.
Conclusions
This study demonstrated significant associations between neuroticism, genetic factors, and amygdala morphology in CMP trajectories, highlighting a potential neurobiological mechanism linking psychological vulnerability to chronic pain. These results underscore the importance of integrating psychological assessment and targeted interventions into comprehensive pain management strategies.